Skyrizi 180 mg

SKYRIZI 180 MG is a subcutaneous solution containing risankizumab, used for managing moderate to severe plaque psoriasis. This biologic medication helps reduce inflammation and improve skin condition.

SKYRIZI 180 MG is primarily used for the treatment of moderate to severe plaque psoriasis in adults. This medication works by targeting specific proteins in the body to reduce inflammation and slow down the overproduction of skin cells. People often ask, 'What is SKYRIZI used for?' and the answer is that it is designed to help manage symptoms of psoriasis, including red, scaly patches on the skin.

Common effects of SKYRIZI 180 MG may include reactions at the injection site, such as redness, itching, or swelling. Some users might experience upper respiratory infections, headache, or fatigue. These effects vary among individuals and are not experienced by everyone.

SKYRIZI 180 MG should be handled with care. It is important to follow the instructions provided by your healthcare professional. Store the medication properly and avoid sharing it with others. Inform your healthcare provider about any allergies or medical conditions before starting treatment.

SKYRIZI 180 MG may interact with other medications, including biologics and immunosuppressants. It is important to discuss all current medications with your healthcare provider to avoid potential interactions. Alcohol and certain foods may also affect how this medication works.